Innovative Vaccine Technologies
Bio tech company
Based in UT
🤖
AI Overview
With $810K in lobbying spend across 20 quarterly filings, Innovative Vaccine Technologies is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2025.
$810K
Total Spend
5
Years Active
1
Firms Hired
4
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $180K |
| 2022 | $240K |
| 2023 | $240K |
| 2024 | $120K |
| 2025 | $30K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Budget/Appropriations
- •FY '22 Appropriations for clinical trials for new vaccine platform
- •FY2022 Appropriation for the development of a synthetic vaccine
- •H.R.___ S.___ FY 2022 Defense Appropriations Bill
- •FY 2022 appropriations for the development of a synthetic vaccine
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.